CIBC World Market
GMAB icon

CIBC World Market’s Genmab GMAB Stock Holding History

CIBC World Market’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.1M Buy
514,764
+26,498
+5% +$704K 0.02% 343
2026
Q1 		$13.1M Buy
488,266
+120,984
+33% +$3.63M 0.02% 333
2025
Q4 		$11.3M Buy
367,282
+87,350
+31% +$2.72M 0.02% 397
2025
Q3 		$8.59M Buy
+279,932
New +$6.82M 0.02% 449
2020
Q4 		– Sell
-49,802
Closed -$1.82M – 1285
2020
Q3 		$1.82M Buy
49,802
+19,046
+62% +$689K 0.01% 512
2020
Q2 		$1.04M Buy
+30,756
New +$838K ﹤0.01% 639

Other funds holding GMAB

PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

CIBC World Market's GMAB Position: Q2 2026 in Review

CIBC World Market increased its Genmab (GMAB) stake by 5.4% in Q2 2026, buying an estimated $704K and bringing the position to 514,764 shares worth $14.1M. The position accounts for 0.02% of the portfolio, ranked #343.

CIBC World Market first reported a position in GMAB in Q2 2020 and has held it in 6 quarters since. 291 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • CIBC World Market held 514,764 shares of Genmab worth $14.1M as of Q2 2026.
  • CIBC World Market bought 26,498 Genmab shares in Q2 2026, an estimated $704K.
  • Genmab made up 0.02% of CIBC World Market's portfolio in Q2 2026, its #343 holding.
  • CIBC World Market first reported a position in Genmab in Q2 2020 and has held it in 6 quarters since.
  • 291 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on CIBC World Market's 13F filing for Q2 2026, filed 13 Aug 2026.